Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies such as imiquimod use different ways to stimulate the immune
system and stop cancer cells from growing. It is not yet known if topical imiquimod is more
effective than surgery in treating basal cell skin cancer.
PURPOSE: This randomized phase III trial is studying how well topical imiquimod works
compared to surgery in treating patients with basal cell skin cancer.